Ventoline 1 mg/ ml ノルウェー - ノルウェー語 - Statens legemiddelverk

ventoline 1 mg/ ml

glaxosmithkline as - salbutamolsulfat - inhalasjonsvæske til nebulisator, oppløsning - 1 mg/ ml

Ventoline 2 mg/ ml ノルウェー - ノルウェー語 - Statens legemiddelverk

ventoline 2 mg/ ml

glaxosmithkline as - salbutamolsulfat - inhalasjonsvæske til nebulisator, oppløsning - 2 mg/ ml

Ventoline 5 mg/ ml ノルウェー - ノルウェー語 - Statens legemiddelverk

ventoline 5 mg/ ml

glaxosmithkline as - salbutamolsulfat - inhalasjonsvæske til nebulisator, oppløsning - 5 mg/ ml

Vetoryl 30 mg ノルウェー - ノルウェー語 - Statens legemiddelverk

vetoryl 30 mg

dechra regulatory b.v. - trilostan - kapsel, hard - 30 mg

Vetoryl 60 mg ノルウェー - ノルウェー語 - Statens legemiddelverk

vetoryl 60 mg

dechra regulatory b.v. - trilostan - kapsel, hard - 60 mg

Vetoryl 120 mg ノルウェー - ノルウェー語 - Statens legemiddelverk

vetoryl 120 mg

dechra regulatory b.v. - trilostan - kapsel, hard - 120 mg

Takipril 20 mg/ ml ノルウェー - ノルウェー語 - Statens legemiddelverk

takipril 20 mg/ ml

b. braun melsungen ag - prilokainhydroklorid - injeksjonsvæske, oppløsning - 20 mg/ ml

Provocholine 100 mg ノルウェー - ノルウェー語 - Statens legemiddelverk

provocholine 100 mg

acic europe limited - metakolinklorid - pulver til inhalasjonsvæske til nebulisator, oppløsning - 100 mg

Yesafili 欧州連合 - ノルウェー語 - EMA (European Medicines Agency)

yesafili

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - Øyemidler - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.